Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SavePreclinical evaluation of KRLS-017, a potent, highly selective and reversible CDK7 inhibitor with broad antitumor effect in preclinical models, in preparation for a Phase 1 clinical trial in advanced solid tumor malignancies
Hannah, Alison L.; Ritland, Steve; Steele, Thomas; Smith, Steven; Ram, Ashwin; Slingsby, B. T.; Dhingra, Kapil; Chrisman, James; Dua, Rajesh; Tokunaga, Yasunori; Kono, Shigeyuki; Aga, Yasuhiro
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save